Administrative Core: Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
Administrative Core: Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
批准号:
10022315
负责人:
WILLIAM A RICKE
金额:
$33.57万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-24 至 2024-07-31
关键词:
5 Alpha-Reductase InhibitorAdrenergic alpha-AntagonistsAffectAgingAmericanAnimal ModelAreaBenignBenign Prostatic HypertrophyBiomedical ResearchBostonBusinessesCell modelCollaborationsCommunicationCommunitiesComputer softwareConsensusCost of IllnessDevelopmentDisciplineDiseaseDoctor of PhilosophyEnsureEquipmentFacultyFibrosisFunctional disorderFundingFunding OpportunitiesFutureGoalsIndividualInstructionLeadLeadershipLettersLifeLinkLower urinary tractMediator of activation proteinMedicalMentored Clinical Scientist Development ProgramMethodsMissionMolecularNational Institute of Diabetes and Digestive and Kidney DiseasesPathway interactionsPatientsPharmaceutical PreparationsPopulationPreclinical TestingProductionProductivityProstateProtocols documentationQuality of lifeReproducibilityResearchResearch PersonnelResearch TrainingResourcesSECTM1 geneScientific SocietiesScientistSeriesServicesSite VisitSpecial EventStudentsSumTherapeuticTissue ModelTrainingTraining ProgramsTranslatingUniversitiesUrinary tractUrologyVisionVoiceWisconsinWorkcellular targetingclinically relevantcostdata disseminationeffectiveness researchexperienceinnovative technologieslower urinary tract symptomsmeetingsmembernew therapeutic targetnext generationorganizational structureoutreach programpatient biomarkerspatient stratificationprogramssymposiumurologic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY - ADMINISTRATIVE CORE
The Administrative Core (Core A), has an overall mission to coordinate and successfully manage the UW-
Madison O’Brien Research Center including UM-Boston and UT-Southwestern and lead benign urology research
into the future. The overarching goal of the O’Brien Center for Benign Urology Research is to identify
mechanisms that result in lower urinary tract dysfunction (LUTD) that result in benign prostatic hyperplasia (BPH)
related lower urinary tract symptoms (LUTS). Criteria for successful completion are defined by the RFA 18-029
and include performing and disseminating outstanding benign urologic research, provide highly needed
resources for the field, and provide outstanding educational enrichment while promoting the next generation of
benign urology researchers. The Center targets new and exciting mechanisms of LUTD namely prostate fibrosis
and translates it to clinically relevant therapeutics and biomarkers for patient stratification. BPH/LUTS can be
life-threatening, affect quality of life, and is a costly disease, which NIDDK wants eradicate. Core A will achieve
these goals by providing outstanding leadership, vision, and efficiency in the overarching administrative duties.
The organization structure and leadership of Core A includes two outstanding investigators with recognized and
complementary abilities in leading research groups and training programs. Dr. Ricke continues to serve as Core
A director and will assume primary responsibility for day to day management and oversight of Core A. He will
also be responsible for obtaining and managing the Opportunity Pool and maintain extensive interactions within
the biomedical community. Dr. Vezina will serve as Associate Director for Core A and will direct the Educational
Enrichment Program. Core A will interact with members of its external advisory board (EAB) and internal advisory
board (IAB) on a semi-annual basis. All members or associated members of the center will be invited to partake
in center functions including seminars, retreats, business meetings, and other special events. Drs. Ricke and
Vezina meet with the NIDDK Executive Steering committee (ESC) and External Expert Panel (EEP) at NIDDK’s
annual reverse site visit (see letter of reference Mark Nelson, PhD, ESC Chair). Their leadership and experience
will allow us to promote interactions between our Center Projects, Core B, as well as other centers (U54, P20,
K12) through: communication, collaboration, and coordination. Further interactions and data dissemination will
occur in conjunction with the NIDDK’s O’Brien Center Interaction core, NIDDK program officials, American
Urological Association Office of Research, scientific societies, and other venues. As directed by NIDDK, the
benign urology research community has a viable focal point--The O’Brien Centers--in which to centralize ideas,
research, resources, training, provide consensus, and offer a unified voice. The O’Brien Centers are more than
the sum of parts, rather they provide leadership, synergize with researchers, and provide to the urology
community above and beyond serving one’s own Center. Core A will lead this NIDDK shared vision.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Estrogen pathways in the development of prostatic fibrosis and lower urinary tract dysfunction
-
批准号:10378476
-
项目类别:
-
资助金额:$51.82万
-
财政年份:2021
-
负责人:WILLIAM A RICKE
-
依托单位:
Estrogen pathways in the development of prostatic fibrosis and lower urinary tract dysfunction
-
批准号:10597683
-
项目类别:
-
资助金额:$51.53万
-
财政年份:2021
-
负责人:WILLIAM A RICKE
-
依托单位:
Elucidating hallmarks of aging in the development of lower urinary tract dysfunction (LUTD)
-
批准号:10346265
-
项目类别:
-
资助金额:$60.27万
-
财政年份:2021
-
负责人:WILLIAM A RICKE
-
依托单位:
Elucidating hallmarks of aging in the development of lower urinary tract dysfunction (LUTD)
-
批准号:10684318
-
项目类别:
-
资助金额:$58.47万
-
财政年份:2021
-
负责人:WILLIAM A RICKE
-
依托单位:
Elucidating hallmarks of aging in the development of lower urinary tract dysfunction (LUTD)
-
批准号:10494151
-
项目类别:
-
资助金额:$58.75万
-
财政年份:2021
-
负责人:WILLIAM A RICKE
-
依托单位:
Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
-
批准号:9921105
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Estrogens stimulate prostatic collagen synthesis to drive fibrosis and LUTD
-
批准号:10700924
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Estrogens stimulate prostatic collagen synthesis to drive fibrosis and LUTD
-
批准号:10264805
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
-
批准号:10331481
-
项目类别:
-
资助金额:$3.52万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Mediators of fibrosis in the development of lower urinary tract dysfunction
-
批准号:9089461
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Mediators of fibrosis in the development of lower urinary tract dysfunction
-
批准号:9353662
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
-
批准号:10700913
-
项目类别:
-
资助金额:$119.68万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Administrative Core: Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
-
批准号:10264803
-
项目类别:
-
资助金额:$46.89万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Mediators of fibrosis in the development of lower urinary tract dysfunction
-
批准号:9343371
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Estrogens stimulate prostatic collagen synthesis to drive fibrosis and LUTD
-
批准号:10022317
-
项目类别:
-
资助金额:$17.49万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
-
批准号:10264802
-
项目类别:
-
资助金额:$69.69万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
-
批准号:10022299
-
项目类别:
-
资助金额:$83.69万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Administrative Core: Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
-
批准号:10700920
-
项目类别:
-
资助金额:$46.9万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Mediators of fibrosis in the development of lower urinary tract dysfunction
-
批准号:9142062
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2014
-
负责人:WILLIAM A RICKE
-
依托单位:
Estrogen Regulation in BPH and the Lower Urinary Tract
-
批准号:8220083
-
项目类别:
-
资助金额:$32.73万
-
财政年份:2011
-
负责人:WILLIAM A RICKE
-
依托单位: